Current understanding of Alzheimer’s disease diagnosis and treatment

Cited by (1,000)

Items 501–600 of 1,000

1. Microglia energy metabolism: A new perspective on Alzheimer's disease treatment
   Qing-Lin Wu, Xiong Yang, Jia-Xin Luo, Li Liu, Ya Zhou, Mei‐Hong Lu · 2025 · Journal of the Neurological Sciences
2. A vagal route to memory: evidence from invasive and non-invasive electrical vagus nerve stimulation studies and areas for future clinical application
   Christoph Szeska, Carlos Ventura‐Bort, Manon Giraudier, Mathias Weymar · 2025 · Frontiers in Human Neuroscience
3. Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research
   Pasindu Hansana Singhaarachchi, Péter Antal, Frédéric Calon, Carsten Culmsee, Jean-Christophe Delpech, Martin Feldotto, Jorine Geertsema, Emmy E. Hoeksema, Anikó Kőrösi, Sophie Layé et al. · 2025 · Progress in Neurobiology
4. Clinical Pharmacists in Chronic Care
   Abdul Kader Mohiuddin · 2019 · Global Journal of Medical Research
5. Glial Cells in Neuroinflammation in Various Disease States
   Derek Barthels, Hiranmoy Das · 2022 · Springer eBooks
6. Analysis of Correlation between Serum Inflammatory Factors and Cognitive Function, Language, and Memory in Alzheimer’s Disease and Its Clinical Significance
   Yan Lu, Jie Li, Tingjun Hu · 2022 · Computational and Mathematical Methods in Medicine · Retracted
7. Biosensors for phytohormone Abscisic acid and its role in humans: A review
   Subodh, Ravina Ravina, P. Priyanka, Jagriti Narang, Hari Mohan · 2023 · Sensors International
8. The journey of F1000Research since inception: through bibliometric analysis
   Dilip Kumar, Abhinav Kumar Shandilya, Sandeep Srivastava · 2023 · F1000Research
9. Total recall: the role of PIDDosome components in neurodegeneration
   Pavel I. Volik, Gelina S. Kopeina, Boris Zhivotovsky, Alexey V. Zamaraev · 2023 · Trends in Molecular Medicine
10. Current Diagnostic and Treatment Methods of Alzheimer’s Disease: A Narrative Review
    Rajshri Dafre, Praful Wasnik · 2023 · Cureus
11. Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
    Laura Ferré‐González, Ángel Balaguer, Marta Roca, Artemis Ftara, Ana Lloret, Consuelo Cháfer‐Pericás · 2024 · Scientific Reports
12. A multi-scale feature selection module based architecture for the diagnosis of Alzheimer’s disease on [18F]FDG PET
    Yuling Wang, Shijie Chen, Xin Tian, Lin Yuan, Dongqi Han, Ping Yao, Hang Xu, Yuanyuan Wang, Jie Zhao · 2024 · International Journal of Medical Informatics
13. Comparison of Malondialdehyde, Acetylcholinesterase, and Apoptosis-Related Markers in the Cortex and Hippocampus of Cognitively Dysfunctional Mice Induced by Scopolamine
    Hee‐Jung Park, Myeong-Hyun Nam, Ji-Hoon Park, Jimin Lee, Hye-Sun Hong, Taewoo Kim, In-Ho Lee, Chang-Ho Shin, Soo‐Hong Lee, Young‐Kwon Seo · 2024 · Biomedicines
14. Zuoguiwan Ameliorates Cognitive Deficits and Neuro-Inflammation in Streptozotocin-Induced Alzheimer’s Disease Rats
    Hong Liu, Lili Zhong, Qiaomei Dai, Jing Yang, Yuwei Zhang, Bo Zhang, Ying Jiang · 2021 · NeuroImmunoModulation
15. The cognitive dysfunction related to Alzheimer disease or cerebral small vessel disease
    Zhenhong Liang, Lijuan Wu, Shumei Gong, Xiaohong Liu · 2021 · Medicine
16. Detecting Brain Structure-Specific Methylation Signatures and Rules for Alzheimer’s Disease
    Zhandong Li, Wei Guo, Tao Zeng, Jie Yin, Kaiyan Feng, Tao Huang, Yu‐Dong Cai · 2022 · Frontiers in Neuroscience
17. A Practical Approach for the Detection of Protein Tau with a Portable Potentiostat
    Münteha Nur Sonuç Karaboğa, Mustafa Kemal Sezgintürk · 2022 · Electroanalysis
18. The Role of Medical Acupuncture Therapy in Alzheimer's Disease
    Yolanda Teja, Dwi Rachma Helianthi, Irma Nareswari · 2021 · Medical Acupuncture
19. Forecasting the 20-Year Incidence of Dementia by Socioeconomic Status, Race/Ethnicity, and Region Based on Mid-Life Risk Factors in a U.S. Nationally Representative Sample
    Nicola Churchill, Deborah E. Barnes, Mina Habib, Roch A. Nianogo · 2024 · Journal of Alzheimer s Disease
20. Synthesis of conjugates of ipidacrine with oxa/azaheterocycles and their potential as agents for the treatment of Alzheimer’s disease
    Ольга Георгиевна Худина, Maria V. Grishchenko, Галина Ф. Махаева, Yanina V. Burgart, Natalia P. Boltneva, Marina V. Goryaeva, Надежда Владимировна Ковалева, Елена Владимировна Рудакова, Сергей Олегович Бачурин, В. И. Салоутин · 2024 · Russian Chemical Bulletin
21. EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression
    Leif E. R. Simmatis, Emma E. Russo, Tayo Steininger, Haleigh Riddell, Evelyn Chen, Queenny Chiu, Michelle Lin, Donghun Oh, Porsha Taheri, Irene E. Harmsen et al. · 2025 · Journal of Alzheimer s Disease
22. Neuroprotective Potential of Phytocompounds in the Treatment of Dementia: The State of Knowledge from the Scopolamine-Induced Animal Model of Alzheimer’s Disease
    Joanna Szala‐Rycaj, Mirosław P. Zagaja, Aleksandra Szewczyk, Jolanta Polak, Marta Andres‐Mach · 2025 · Current Issues in Molecular Biology
23. Global trends in Alzheimer’s disease and other dementias in adults aged 55 and above (1992–2021): An age-period-cohort analysis based on the GBD 2021
    Qianqian Zhang, Yanwen Deng, Mo Xue, Zihan Ni, Guangyan Luo, Tian Kan · 2025 · PLoS ONE
24. Calpain Inhibitor Calpeptin Improves Alzheimer’s Disease–Like Cognitive Impairments and Pathologies in a Diabetes Mellitus Rat Model
    Min Li, Siqi Zhou, Gege Wang, Luyao Qiao, Shouqin Yi, Tianpei Li, Xin Pan, Xu Liu, Zhenyu Tang · 2022 · Neurotoxicity Research
25. Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease using Conjugates of Serotonin with Sesquiterpene Lactones
    Неганова Маргарита Евгеньевна, Junqi Liu, Yulia R. Aleksandrova, Natalia Vasilieva, А. В. Семаков, Ekaterina Yu. Yandulova, Olga A. Sukocheva, Konstantin V. Balakin, Sergey G. Klochkov, Ruitai Fan · 2022 · Current Medicinal Chemistry
26. Alpha-Linolenic acid: A Pharmacologically Active Ingredient from Nature
    Devika Srivastava, Vandana Singh, Umesh Kumar, Venkatesh Kumar R · 2021 · The Indian Journal of Nutrition and Dietetics
27. Structure, function and mechanism of edible fungus polysaccharides in human beings chronic diseases
    Huijuan Liu, Xiaoyi LIU, Jiao Xie, Shuai CHEN · 2023 · Food Science and Technology
28. Potential drugs for the treatment of Alzheimer’s disease
    Tania Guadalupe Montero-Cosme, Luz Irene Pascual-Mathey, María Elena Hernández‐Aguilar, Deissy Herrera‐Covarrubias, Fausto Rojas-Durán, Gonzálo Emiliano Aranda-Abreu · 2023 · Pharmacological Reports
29. Kaempferol treatment ameliorates memory impairments in STZ‑induced neurodegeneration by acting on reelin signaling
    Melike Uysal, Mert Çelikten, Merve Beker, Nurhayat Polat, Önder Hüseyinbaş, Şule Terzioğlu Uşak, Birsen Elibol · 2023 · Acta Neurobiologiae Experimentalis
30. Multimodal imaging investigation of structural rich club alterations in Alzheimer's disease and mild cognitive impairment: Amyloid deposition, structural atrophy, and functional activation differences
    Sebastian A. Markett, Ole Jonas Boeken, Olga A. Wudarczyk, the Alzheimer’s Disease Neuroimaging Initiative · 2024 · European Journal of Neuroscience
31. TRPC1: The housekeeper of the hippocampus
    Julia Skerjanz, Lena Bauernhofer, Kerstin Lenk, Anita Emmerstorfer‐Augustin, Gerd Leitinger, Florian Reichmann, Thomas Stockner, Klaus Groschner, Oleksandra Tiapko · 2024 · Cell Calcium
32. Therapeutic Potential of Polyphenols in Cellular Reversal of Patho‐Mechanisms of Alzheimer's Disease Using In Vitro and In Vivo Models: A Comprehensive Review
    Monalisha Samal, Varsha Srivastava, Muzayyana Khan, Areeba Insaf, Naveen Reddy Penumallu, Aftab Alam, Bushra Parveen, Shahid Hussain Ansari, Sayeed Ahmad · 2024 · Phytotherapy Research
33. Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management
    Aviral Kumar, Kenneth Chun-Hong Yap, Bandari BharathwajChetty, Juncheng Lyu, Mangala Hegde, Mohamed Abbas, Mohammed S. Alqahtani, Soham Khadlikar, Ali Zarrabi, Arezoo Khosravi et al. · 2024 · Journal of Biomedical Science
34. Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation
    Chenhui Zhao, W. Qi, X. Lv, Xue-Li Gao, Chao-Nan Liu, Shi-Min Zheng · 2025 · CNS Neuroscience & Therapeutics
35. Accurate characterization of β-amyloid (Aβ40, Aβ42) standards using species-specific isotope dilution by means of HPLC-ICP-MS/MS
    Martin Schaier, Gerrit Hermann, Gunda Koellensperger, Sarah Theiner · 2021 · Analytical and Bioanalytical Chemistry
36. Joint Analysis of Genome-Wide Association Data Reveals No Genetic Correlations Between Low Back Pain and Neurodegenerative Diseases
    Pengfei Wu, Bing Du, Bing Wang, Rui Yin, Xin Lv, Yuliang Dai, Wan Zhang, Kun Xia · 2021 · Frontiers in Genetics
37. Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool
    Amir Abbas Tahami Monfared, William R. Lenderking, Yulia Savva, Mary Kate Ladd, Quanwu Zhang, Alzheimer’s Disease Neuroimaging Initiative, James B. Brewer, Oscar L. López, Bradley T. Hyman, Thomas J. Grabowski et al. · 2022 · Neurology and Therapy
38. New azole-derived hemiaminal ethers as promising acetylcholinesterase inhibitors: synthesis, X-ray structures, in vitro and in silico studies
    Muhammad Nisar, Humaira Yasmeen Gondal, Zain Maqsood Cheema, Sammer Yousaf, Humaira Nadeem · 2023 · Journal of Biomolecular Structure and Dynamics
39. Extensive Structure Modification on Luteolin-Cinnamic Acid Conjugates Leading to BACE1 Inhibitors with Optimal Pharmacological Properties
    Deyang Sun, Cheng Chen, Katrin Moschke, Jian Huang, Wei‐Shuo Fang · 2019 · Molecules
40. Natural Medicines and Their Underlying Mechanisms of Prevention and Recovery from Amyloid Β-Induced Axonal Degeneration in Alzheimer’s Disease
    Tomoharu Kuboyama, Ximeng Yang, Chihiro Tohda · 2020 · International Journal of Molecular Sciences
41. A Review of CRISPR Cas9 for Alzheimer’s Disease: Treatment Strategies and Could target APOE e4, APP, and PSEN-1 Gene using CRISPR cas9 Prevent the Patient from Alzheimer’s Disease?
    Arga Setyo Adji, Jordan Steven Widjaja, Vira Aulia Kusuma Wardani, Alvian Habib Muhammad, Fitri Handajani, Hendy Bhaskara Perdana Putra, Firman Suryadi Rahman · 2022 · Open Access Macedonian Journal of Medical Sciences
42. Cost-effectiveness analysis of aducanumab versus placebo for patients with mild cognitive impairment and mild Alzheimer’s disease
    Xiaomo Xiong, Gang Lv, Jacob Jordan King, Minghui Li, Jing Yuan, Kevin Lu · 2025 · BMJ Open
43. miR-590-5p Overexpression Alleviates β-Amyloid-Induced Neuron Damage via Targeting Pellino-1
    Shang Lin, Tao Peng, Xuemei Chen, Zhiyong Yan, Junmin Wang, Xiaoqun Gao, Cheng Kuei Chang · 2022 · Analytical Cellular Pathology
44. Relation of Progression of Coronary Artery Calcium to Dementia (from the Multi-Ethnic Study of Atherosclerosis)
    Gary S Huang, Spencer L. Hansen, Robyn L. McClelland, Annette L. Fitzpatrick, William T. Longstreth Jr., Matthew Jay Budoff, Nathan D. Wong, Akira Fujiyoshi, Younghoon Kwon, Timothy M. Hughes et al. · 2022 · The American Journal of Cardiology
45. Oxidative stress of mitophagy in neurodegenerative diseases: Mechanism and potential therapeutic targets
    Yixin Li, Wanying Zhang, Qihang Zhang, Yunzhe Li, Chonghui Xin, Rongze Tu, Haijing Yan · 2024 · Archives of Biochemistry and Biophysics
46. Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data
    Wukun Ge, Yingyan Yan, Yaoyao Hu, Shuainan Lin, Peizhi Mao · 2025 · Journal of Alzheimer s Disease
47. Histone Deacetylation in Alzheimer’s Diseases (AD); Hope or Hype
    N. H. Ateya, S. Al-Taie, S. Jasim, S. Uthirapathy, Kamlesh Chaudhary, Pooja Rani, M. Kundlas, K. Naidu, Nevin Adel Amer Amer, Jawad Kadhim Ahmed · 2025 · Cell Biochemistry and Biophysics
48. A review of pharmacological mechanisms, challenges and prospects of macromolecular glycopeptides
    Ye Gao, Xiaoyi Chen, Jin‐Ao Duan, Ping Xiao · 2025 · International Journal of Biological Macromolecules
49. Frequent fecal microbiota transplantation improves cognitive impairment and pathological changes in Alzheimer's disease FAD4T mice via the microbiota-gut-brain axis
    Zhiyan Zou, Dan Lei, Yuan Yin, Ruiling Xu, Huiwen Luo, Tingting Chen, Mingxue Liu, Xiaoan Li · 2025 · Heliyon
50. Zeaxanthin Attenuates the Vicious Circle Between Endoplasmic Reticulum Stress and Tau Phosphorylation: Involvement of GSK-3β Activation
    Li-Na Zhang, Meng-Jie Li, Ying-Hui Shang, Yun-Ru Liu, Huang Han-Chang, Feng-Xue Lao · 2022 · Journal of Alzheimer s Disease
51. Phytochemical based Modulation of Endoplasmic Reticulum Stress in Alzheimer's Disease
    Venzil Lavie Dsouza, Apoorva Bettagere Shivakumar, Nikshitha Kulal, Gireesh Gangadharan, Dileep Kumar, Shama Prasada Kabekkodu · 2022 · Current Topics in Medicinal Chemistry
52. Efficient Deep Learning Algorithm for Alzheimer's Disease Diagnosis using Retinal Images
    Do Young Kim, Young Jun Lim, Joon Hyeon Park, Myung Hoon Sunwoo · 2022 · IEEE International Conference on Artificial Intelligence Circuits and Systems (AICAS)
53. Molecular Design of Magnetic Resonance Imaging Agents Binding to Amyloid Deposits
    Alena A. Nikiforova, Igor A. Sedov · 2023 · International Journal of Molecular Sciences
54. Efficacy and safety of gantenerumab in the treatment of Alzheimer's disease: A meta-analysis of randomized controlled trials
    Milene Vitória Sampaio Sobral, Victor Gonçalves Soares, Ocílio Ribeiro Gonçalves, Victoria Städler de Abreu, Lucas Cael Azevedo Ramos Bendaham, Brenda Letícia Lopes Batista, Marco Antonnio Rocha dos Santos · 2024 · Archives of Gerontology and Geriatrics Plus
55. An Animal Model to Test Reversal of Cognitive Decline Associated with Beta-Amyloid Pathologies
    Farah Deba, Steven L. Peterson, Ayman K. Hamouda · 2019 · Methods in molecular biology
56. Misfolded proteins as a therapeutic target in Alzheimer's disease
    S. Imindu Liyanage, Donald Fredric Weaver · 2019 · Advances in protein chemistry and structural biology
57. In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
    Bikash Medhi, Manisha Prajapat, Phulen Sarma, Nishant Shekhar, Hardeep Kaur, Sanjay Kumar Singh, Subodh Kumar, Harpinder Kaur, Saniya Mahendiratta, Amit Raj Sharma et al. · 2020 · Journal of Advanced Pharmaceutical Technology amp Research
58. Association of Alzheimer’s Disease with Genetic Variants of Apolipoprotein E, Clusterin, TNF-α, and IL-6 Among Elderly Saudis
    Saba Abdi, Amani Ahmed Alghamdi, Nouf Nasser Abduallah AlGhunaim, Reem Mohammed Almutairi, Farid Shokry Ataya, Mohammed Ghouse Ahmed Ansari, Syed Danish Hussain, Mohammad S. Masoud, Abir Abdullah Alamro, Othman T. Almutairi et al. · 2022 · Current Pharmaceutical Biotechnology
59. Eye Movement in Neurological Disorders
    Julia Das, Lisa Graham, Rosie Morris, Gill Barry, Alan Godfrey, Richard William Walker, Samuel Stuart · 2022 · Neuromethods
60. Therapeutic Intervention of Neuroinflammatory Alzheimer Disease Model by Inhibition of Classical Complement Pathway with the Use of Anti-C1r Loaded Exosomes
    Richards, Terjahna, Perron, Jeanette C., Patel, Ketan, Wurpel, John, Reznik, Sandra E., Schanne, Francis · 2023
61. The Turkish validity and reliability of Addenbrooke's Cognitive Examination III
    Mümüne Merve Parlak, Özlem Bizpınar Munis, Ayşen Köse, CANSU YILDIRIM, Cemil Arcan Ülker · 2024 · International Journal of Language & Communication Disorders
62. Astrocytic GluN2A alleviates sleep deprivation-induced elevation of Aβ through regulating neprilysin and AQP4 via the calcineurin/NFAT pathway
    Xiaoqiang Du, Hongqi Wang, Siyu Liu, Yizhi Song, Xinyue Chen, Ziyan Chen, Ruying Zhou, Jiahe Du, Wanning Zhang, Ruiqi Gao et al. · 2025 · Progress in Neurobiology
63. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome
    Jacob Dohl, Zoe Treadwell, Christopher Mark Norris, Elizabeth Head · 2025 · Alzheimer s & Dementia
64. An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer’s disease
    Juan Fortea, Elena Ferrer-Picón · 2025 · Expert Review of Neurotherapeutics
65. Impact of Gut–Brain Axis and Probiotics on Alzheimer’s Disease
    Raghad Tabaza, Richard E. Hartman · 2025 · Neurology International
66. Neuroglial Function and Hormonal Modulation in Neurodegenerative Diseases: The Influence of Sex Hormones
    Maitha M. Alhajeri, Yara Abukhaled, Rayyah R. Alkhanjari, Wesam Bassiouni, Hana Al-Ali, Amna Baig, Sara H. Sembaij, Fatima A. Al Muhairi, Zakia Dimassi, Hamdan Hamdan et al. · 2026 · Cellular and Molecular Neurobiology
67. Developing a Korean Version of the Scale for the Observation of Agitation in Persons with Dementia of Alzheimer-Type
    Eun Young Kim, Ye‐Na Lee, Eunhye Jeong, Sung Ok Chang · 2020 · Journal of Korean Gerontological Nursing
68. Pterostilbene fluorescent probes as potential tools for targeting neurodegeneration in biological applications
    Lidia Ciccone, Susanna Nencetti, Maria Marino, Chiara Battocchio, Giovanna Iucci, Iole Venditti, Martina Marsotto, Emiliano Montalesi, Simone Socci, Beatrice Bargagna et al. · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
69. A zero-dose synthetic baseline for the personalized analysis of [18F]FDG-PET: Application in Alzheimer’s disease
    Christian Hinge, Otto Mølby Henriksen, Ulrich Lindberg, Steen Gregers Hasselbalch, Liselotte Højgaard, Ian G. Law, Flemming Littrup Andersen, Claes Nøhr Ladefoged · 2022 · Frontiers in Neuroscience
70. Review Current and Emerging Treatment Options for Alzheimer's Disease
    Dimple Kumar Vats, Nistara Biswas, Preethi Pandian, Anupam Kamalakannan · 2023 · Neurology Letters
71. Zebrafish Experimental Animal Models for AD: A Comprehensive Review
    Ruksar Sande, Angel Pavalu Godad, Gaurav Doshi · 2024 · Current Clinical Pharmacology
72. The features analysis of hemoglobin expression on visual information transmission pathway in early stage of Alzheimer’s disease
    Xuehui Li, Pan Tang, Xinping Pang, Xianghu Song, Jing Xiong, Lei Yu, Hui Liu, Chao-Yang Pang · 2024 · Scientific Reports
73. Interconnections between the Gut Microbiome and Alzheimer’s Disease: Mechanisms and Therapeutic Potential
    Ahmad M Sait, Philip J. Day · 2024 · International Journal of Molecular Sciences
74. Mini-mental status examination phenotyping for Alzheimer’s disease patients using both structured and narrative electronic health record features
    Betina Idnay, Gongbo Zhang, Fangyi Chen, Casey Ta, Matthew W. Schelke, Karen S. Marder, Chunhua Weng · 2024 · Journal of the American Medical Informatics Association
75. Implications of the Gut Microbiome in Alzheimer’s Disease: A Narrative Review
    Palvi Mroke, Raman Goit, Muhammad Rizwan, Saba Tariq, Abdul Wahid Rizwan, Muhammad Umer, Fariha F Nassar, Angela Juliet Torijano Sarria, Dilpreet Singh, Imran Baig · 2024 · Cureus
76. Effects and mechanisms of APP and its cleavage product Aβ in the comorbidity of sarcopenia and Alzheimer’s disease
    Jiale Wu, Jun Tang, Di Huang, Yu Wang, Enyuan Zhou, Qin Ru, Guodong Xu, Lin Chen, Yuxiang Wu · 2024 · Frontiers in Aging Neuroscience
77. Uncovering the intricacies of O-GlcNAc modification in cognitive impairment: New insights from regulation to therapeutic targeting
    Jianhui Wang, Ning Jiang, Feng Liu, Chenran Wang, Wenxia Zhou · 2024 · Pharmacology & Therapeutics
78. The Role and Mechanisms of Ubiquitin-Proteasome System-Mediated Ferroptosis in Neurological Disorders
    Xin Liu, Wei Wang, Qiucheng Nie, Xinjing Liu, Lili Sun, Qiang Ma, Jie Zhang, Yiju Wei · 2025 · Neuroscience Bulletin
79. Recent Insights into Bioactive Dichalcogen Derivatives: From Small Molecules to Complex Materials
    Leire Gaviria-Soteras, Arun Kumar Sharma, Carmen Sanmartín, Daniel Plano · 2025 · International Journal of Molecular Sciences
80. Hospital incidence, mortality and costs of Alzheimer’s disease in Spain: a retrospective multicenter study
    Josep Darbà, Alícia Marsà · 2020 · Expert Review of Pharmacoeconomics & Outcomes Research
81. Assessing the Possible Influence of Residues of Ractopamine, a Livestock Feed Additive, in Meat on Alzheimer Disease
    Frank Sheng Fan · 2021 · Dementia and Geriatric Cognitive Disorders Extra
82. Exploration of potential circulating micro-RNA as biomarker for Alzheimer's disease
    Mahsa Abolghasemi, Elham Poursaei, Soghra Bornehdeli, Dariush Shanehbandi, Milad Asadi, Mahsa Sadeghzadeh, Reza Naghdi Sadeh · 2021 · Meta Gene
83. Therapeutic potential of Allium Sativum against the Aβ(1-40)-induced oxidative stress and mitochondrial dysfunction in the Wistar rats.
    Neetu Saini, Monika Kadian, Alka Khera, Aanchal Aggarwal, Anil Kumar · 2021 · PubMed Central
84. Protective Effects of Isothiocyanates against Alzheimer's Disease
    Mohammad Asif, Chandra Kala, Sadaf Jamal Gilani, Syed Sarim Imam, Mohamad Taleuzzaman, Farha Naaz, Iqra Rahat, Najam Ali Khan · 2021 · Current Traditional Medicine
85. Integrative analysis of OIP5-AS1/miR-129-5p/CREBBP axis as a potential therapeutic candidate in the pathogenesis of metal toxicity-induced Alzheimer's disease
    Rohan V. Gupta, Pravir Kumar · 2021 · Gene Reports
86. The Future of Artificial Intelligence for Alzheimer’s Disease Diagnostics
    Robert A Logan, Sabrina S. Zerbey, Sean Miller · 2021 · Advances in Alzheimer s Disease
87. Prospective Evaluation of an Amide-Based Zinc Scaffold as an Anti-Alzheimer Agent: In Vitro, In Vivo, and Computational Studies
    Wajeeha Waseem, Fareeha Anwar, Uzma Saleem, Bashir Ahmad, Rehman Zafar, Asifa Anwar, Muhammad Saeed Jan, Umer Rashid, Abdul Sadiq, Tariq Ismail · 2022 · ACS Omega
88. Novel mathematical model based on cellular automata for study of Alzheimer’s disease progress
    Niloofar Jafari, Yashar Sarbaz, Abbas Ebrahimi Kalan, Faegheh Golabi · 2022 · Network Modeling Analysis in Health Informatics and Bioinformatics
89. Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19
    Hui Jue Wang, Raphael W. Kusumo, Alex Kiss, Gayla Tennen, Giovanni Marotta, Shirley Viaje, Krista L. Lanctôt · 2023 · Journal of Alzheimer s Disease Reports
90. Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis
    Sofia I. Petersen, Rachel K. Okolicsanyi, Larisa Margaret Haupt · 2024 · Cellular and Molecular Neurobiology
91. Efficient Deep Retinal Fundus Image-Based Network for Alzheimer’s Disease Diagnosis Using Mobile Device Applications
    Do Young Kim, Ho Keun Kim, Young Jun Lim, Myung Hoon Sunwoo · 2024 · IEEE Access
92. Applications of Hybrid PET/Magnetic Resonance Imaging in Central Nervous System Disorders
    Austin J. Borja, Emily C. Hancin, Mohsen Khosravi, Rina Ghorpade, Benjamin Koa, Xuan Miao, Thomas J. Werner, Andrew B. Newberg, Abass A. Alavi · 2020 · PET Clinics
93. Multitarget Effect of 2-(4-(Methylthio)phenyl)-3-(3-(piperidin-1-yl)propyl)thiazolidin-4-one in a Scopolamine-Induced Amnesic Rat Model
    Daniel Schuch da Silva, Mayara Sandrielly Pereira Soares, Fernanda Cardoso Teixeira, Júlia Eisenhardt de Mello, Anita Ávila de Souza, Karina Pereira Luduvico, Cínthia Melazzo de Andrade, Rosélia Maria Spanevello, Wilson João Cunico · 2021 · Neurochemical Research
94. Effect of Memantine on QT/QTc Interval in a Healthy Korean Population
    Jin‐Woo Park, Kyoung‐Ah Kim, Ji Young Park · 2021 · Clinical Pharmacology in Drug Development
95. WaterMap‐Guided Structure‐Based Virtual Screening for Acetylcholinesterase Inhibitors
    Katarzyna M. Targowska‐Duda, Maciej Maj, Piotr Drączkowski, Barbara Budzyńska, Anna Boguszewska‐Czubara, Tomasz M. Wróbel, Tuomo Laitinen, Patrycja Kaczmar, Antti Poso, Agnieszka Anna Kaczor · 2022 · ChemMedChem
96. Z-scan optical method complements the Thioflavin T assay for investigation of anti-Alzheimer's impact of polyphenols
    Mohammad Jamali, Salman Mohajer, Sara Sheikhlary, Mohammad Hossien Majles Ara · 2022 · Photodiagnosis and Photodynamic Therapy
97. Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors
    George Dranitsaris, Quanwu Zhang, Alex Quill, Lin Mu, Christopher Weyrer, Erik Dysdale, Peter J. Neumann, Amir Abbas Tahami Monfared · 2022 · Neurology and Therapy
98. Leptin ameliorates Aβ1-42-induced Alzheimer’s disease by suppressing inflammation via activating p-Akt signaling pathway
    Lin Lu, Zijuan Fu, Bing Wu, Dongsen Zhang, Ying Wang · 2023 · Translational Neuroscience
99. miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease
    Emad M. Elzayat, Sherif A. Shahien, Ahmed Abdou El-Sherif, Mohamed Hosney · 2023 · Journal of Alzheimer s Disease
100. Elucidating the Risk Factors for Progression from Amyloid-Negative Amnestic Mild Cognitive Impairment to Dementia
     Hyung‐Ji Kim, Jae‐Hong Lee, E‐Nae Cheong, Sung-eun Chung, Sungyang Jo, Woo Hyun Shim, Yun Jeong Hong · 2020 · Current Alzheimer Research